Astellas Pharma
(OTC) ALPMY
Astellas Pharma Financials at a Glance
Market Cap
$23.83B
Revenue (TTM)
¥2.27T
Net Income (TTM)
¥309.12B
EPS (TTM)
$1.08
P/E Ratio
12.28
Dividend
$0.50
Beta (Volatility)
0.31 (Low)
Dividend
$0.50
Beta (Volatility)
0.31 (Low)
Price
$13.30
Volume
194,032
Open
$13.32
Price
$13.30
Volume
194,032
Open
$13.32
Previous Close
$13.30
Daily Range
$13.23 - $13.41
52-Week Range
$9.22 - $17.35
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.50
Beta (Volatility)
0.31 (Low)
Price
$13.30
Volume
194,032
Open
$13.32
Previous Close
$13.30
Daily Range
$13.23 - $13.41
52-Week Range
$9.22 - $17.35
Estimated Earnings Date
Jul 29, 2026
ALPMY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Astellas Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
14,099
CEO
Naoki Okamura
Website
www.astellas.comHeadquarters
Tokyo, 103-8411, JP
ALPMY Financials
Key Financial Metrics (TTM)
Gross Margin
76.08%
Operating Margin
18.92%
Net Income Margin
13.63%
Return on Equity
17.44%
Return on Capital
21.33%
Return on Assets
8.17%
Earnings Yield
8.14%
Dividend Yield
3.72%
Payout Ratio
46.68%
Stock Overview
Market Cap
$23.83B
Shares Outstanding
1.79B
Volume
194.03K
Avg. Volume
183.80K
Financials (TTM)
Gross Profit
¥1.69T
Operating Income
¥445.01B
EBITDA
¥445.01B
Operating Cash Flow
¥574.51B
Capital Expenditure
-¥58.44B
Free Cash Flow
¥516.06B
Cash & ST Invst.
¥282.83B
Total Debt
¥675.27B
Astellas Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
¥647.49B
+41.0%
Gross Profit
¥457.56B
+19.6%
Gross Margin
70.67%
N/A
Market Cap
$23.83B
N/A
Market Cap/Employee
$1.61M
N/A
Employees
14,754
N/A
Net Income
¥57.97B
-22.6%
EBITDA
-¥52.63B
-151.7%
Quarterly Fundamentals
Total Cash
¥282.83B
+29.6%
Total Debt
¥675.27B
-18.8%
Accounts Receivable
¥765.07B
+21.0%
Inventory
¥332.45B
+11.8%
Long Term Debt
¥410.56B
-27.3%
Short Term Debt
¥264.71B
-0.7%
Return on Assets
8.17%
N/A
Return on Invested Capital
17.24%
N/A
Free Cash Flow
¥191.01B
+109.0%
Operating Cash Flow
¥207.50B
+105.3%